10-99850966-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000392.5(ABCC2):​c.4508+170A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 152,070 control chromosomes in the GnomAD database, including 13,260 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.41 ( 13260 hom., cov: 33)

Consequence

ABCC2
NM_000392.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.994

Publications

5 publications found
Variant links:
Genes affected
ABCC2 (HGNC:53): (ATP binding cassette subfamily C member 2) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008]
ABCC2 Gene-Disease associations (from GenCC):
  • Dubin-Johnson syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 10-99850966-A-G is Benign according to our data. Variant chr10-99850966-A-G is described in ClinVar as Benign. ClinVar VariationId is 1180976.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.426 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC2NM_000392.5 linkc.4508+170A>G intron_variant Intron 31 of 31 ENST00000647814.1 NP_000383.2
ABCC2XM_006717630.4 linkc.3812+170A>G intron_variant Intron 26 of 26 XP_006717693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC2ENST00000647814.1 linkc.4508+170A>G intron_variant Intron 31 of 31 NM_000392.5 ENSP00000497274.1
ABCC2ENST00000648523.1 linkn.*349+170A>G intron_variant Intron 4 of 4 ENSP00000497778.1

Frequencies

GnomAD3 genomes
AF:
0.413
AC:
62767
AN:
151952
Hom.:
13253
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.416
Gnomad AMI
AF:
0.546
Gnomad AMR
AF:
0.419
Gnomad ASJ
AF:
0.477
Gnomad EAS
AF:
0.234
Gnomad SAS
AF:
0.344
Gnomad FIN
AF:
0.359
Gnomad MID
AF:
0.532
Gnomad NFE
AF:
0.431
Gnomad OTH
AF:
0.437
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.413
AC:
62826
AN:
152070
Hom.:
13260
Cov.:
33
AF XY:
0.409
AC XY:
30396
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.417
AC:
17275
AN:
41476
American (AMR)
AF:
0.419
AC:
6406
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
1656
AN:
3470
East Asian (EAS)
AF:
0.233
AC:
1205
AN:
5182
South Asian (SAS)
AF:
0.344
AC:
1658
AN:
4824
European-Finnish (FIN)
AF:
0.359
AC:
3791
AN:
10554
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.431
AC:
29264
AN:
67972
Other (OTH)
AF:
0.436
AC:
921
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1900
3800
5699
7599
9499
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.431
Hom.:
24546
Bravo
AF:
0.418
Asia WGS
AF:
0.298
AC:
1038
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.43
DANN
Benign
0.24
PhyloP100
-0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3740063; hg19: chr10-101610723; API